Difference between revisions of "Template:Antigonadotropic effects of estradiol undecylate"
Jump to navigation
Jump to search
blackwiki>Rjwilmsi m (→top: Journal cites:, added 1 PMID) |
m (6 revisions imported) |
(No difference)
| |
Latest revision as of 14:18, 22 October 2020
- Antigonadotropic effects of estradiol undecylate
- Testosterone levels with 300 mg per week cyproterone acetate and 100 mg per month estradiol undecylate by intramuscular injection.png
Testosterone levels with 300 mg/week cyproterone acetate or 100 mg/month estradiol undecylate both by intramuscular injection.[1] The solid lines are the average levels and the dashed lines are the highest and lowest observed levels.
- Estradiol, testosterone, and prolactin levels during therapy with 100 mg per month estradiol undecylate in men with prostate cancer.png
Estradiol, testosterone, and prolactin levels with 100 mg/month estradiol undecylate by intramuscular injection in men with prostate cancer.[2]
See also
References
- ↑ Jacobi GH, Altwein JE, Kurth KH, Basting R, Hohenfellner R (1980). "Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial". Br J Urol. 52 (3): 208–15. doi:10.1111/j.1464-410x.1980.tb02961.x. PMID 7000222.
- ↑ Jacobi, G.H.; Altwein, J.E. (1979). "Bromocriptin als Palliativtherapie beim fortgeschrittenen Prostatakarzinom:Experimentelles und klinisches Profil eines Medikamentes" [Bromocriptine as Palliative Therapy in Advanced Prostate Cancer: Experimental and Clinical Profile of a Drug]. Urologia Internationalis. 34 (4): 266–290. doi:10.1159/000280272. ISSN 1423-0399. PMID 89747.
